Lyubomir T. Vassilev
Papers
1
Total Citations
234
H-Index
1
About
Lyubomir T. Vassilev is a pioneering molecular biologist whose research has fundamentally reshaped our understanding of the p53 tumor suppressor pathway and targeted cancer therapy. His most influential work challenged long-held dogma by demonstrating, through genetic models, that phosphorylation of p53 at key serine residues is dispensable for its transcriptional activation and apoptotic functions—a finding with over 230 citations that redefined how scientists view p53 regulation. Vassilev is perhaps best known for his groundbreaking discovery of Nutlin-3, the first small-molecule inhibitor of the MDM2-p53 interaction, which reactivates wild-type p53 in cancer cells and has become a cornerstone compound in oncology research. This work, published in *Science* in 2004, opened an entirely new avenue for targeted cancer therapeutics and has been cited thousands of times. His contributions have earned him recognition as a leader in the field, with his research bridging fundamental tumor biology and translational drug development. For students and researchers, Vassilev’s career exemplifies how rigorous mechanistic studies can lead to paradigm-shifting discoveries with direct clinical implications.
Research Focus
Key Achievements
Top Papers
- 1